Cargando…

Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab: a case series from Poland

Detalles Bibliográficos
Autores principales: Stelmach, Iwona, Majak, Paweł, Jerzyńska, Joanna, Bojo, Magdalena, Cichalewski, Łukasz, Smejda, Katarzyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548025/
https://www.ncbi.nlm.nih.gov/pubmed/26322106
http://dx.doi.org/10.5114/aoms.2015.48546
_version_ 1782387137525579776
author Stelmach, Iwona
Majak, Paweł
Jerzyńska, Joanna
Bojo, Magdalena
Cichalewski, Łukasz
Smejda, Katarzyna
author_facet Stelmach, Iwona
Majak, Paweł
Jerzyńska, Joanna
Bojo, Magdalena
Cichalewski, Łukasz
Smejda, Katarzyna
author_sort Stelmach, Iwona
collection PubMed
description
format Online
Article
Text
id pubmed-4548025
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-45480252015-08-28 Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab: a case series from Poland Stelmach, Iwona Majak, Paweł Jerzyńska, Joanna Bojo, Magdalena Cichalewski, Łukasz Smejda, Katarzyna Arch Med Sci Letter to the Editor Termedia Publishing House 2015-08-11 2015-08-12 /pmc/articles/PMC4548025/ /pubmed/26322106 http://dx.doi.org/10.5114/aoms.2015.48546 Text en Copyright © 2015 Termedia & Banach http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Stelmach, Iwona
Majak, Paweł
Jerzyńska, Joanna
Bojo, Magdalena
Cichalewski, Łukasz
Smejda, Katarzyna
Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab: a case series from Poland
title Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab: a case series from Poland
title_full Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab: a case series from Poland
title_fullStr Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab: a case series from Poland
title_full_unstemmed Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab: a case series from Poland
title_short Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab: a case series from Poland
title_sort children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab: a case series from poland
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548025/
https://www.ncbi.nlm.nih.gov/pubmed/26322106
http://dx.doi.org/10.5114/aoms.2015.48546
work_keys_str_mv AT stelmachiwona childrenwithsevereasthmacanstartallergenimmunotherapyaftercontrollingasthmawithomalizumabacaseseriesfrompoland
AT majakpaweł childrenwithsevereasthmacanstartallergenimmunotherapyaftercontrollingasthmawithomalizumabacaseseriesfrompoland
AT jerzynskajoanna childrenwithsevereasthmacanstartallergenimmunotherapyaftercontrollingasthmawithomalizumabacaseseriesfrompoland
AT bojomagdalena childrenwithsevereasthmacanstartallergenimmunotherapyaftercontrollingasthmawithomalizumabacaseseriesfrompoland
AT cichalewskiłukasz childrenwithsevereasthmacanstartallergenimmunotherapyaftercontrollingasthmawithomalizumabacaseseriesfrompoland
AT smejdakatarzyna childrenwithsevereasthmacanstartallergenimmunotherapyaftercontrollingasthmawithomalizumabacaseseriesfrompoland